🌐 Nasdaq-listed healthcare innovator | $300M Ethereum treasury reserve | Compliance transparency powering tomorrow’s balance sheets
Joined October 2018
- Tweets 751
- Following 176
- Followers 19,510
- Likes 383
95 Photos and videos
Pinned Tweet
Robotic automation, smart logistics, and ongoing facility upgrades are fueling strong momentum at our pharmaceutical wholesale subsidiary, Cosmofarm, as record performance continues with accelerating customer growth, improving unit economics, and expanded delivery routes.
$COSM
4
5
12
2,934
@CosmosHealthInc provides update on United States portfolio. Four 18 Series products introduced with projected annualized revenue over $22.7M and approximately $17.0M gross profit.
$COSM
globenewswire.com/news-relea…
3
5
299
@CosmosHealthInc receives new contract manufacturing orders totaling 253,657 units across a range of medicines.
$COSM
globenewswire.com/news-relea…
3
2
7
327
@CosmosHealthInc reports annualized sales exceeding $1.5M for its C-Scrub and C-Sept antiseptic brands in the UK and Greece; plans EU expansion targeting $7.4M in revenue and $5.3M in gross profit.
$COSM
globenewswire.com/news-relea…
1
4
225
@CosmosHealthInc signs LOI to acquire Doc Pharma S.A., a European GMP pharmaceutical manufacturer, a transformative step expected to boost assets, profitability, production capacity, and product portfolio.
$COSM
globenewswire.com/news-relea…
5
6
383
@CosmosHealthInc secures additional 180-day Nasdaq extension to regain bid price compliance.
Extension granted through December 7, 2026. Reflects the Company's compliance with all other applicable Nasdaq listing requirements.
$COSM
globenewswire.com/news-relea…
1
4
9
304
@CosmosHealthInc signs 3-year contract manufacturing agreement with Verisfield for 3.9 Million units of VASCLOR GEST progesterone pessaries.
$COSM
globenewswire.com/news-relea…
4
6
386
@CosmosHealthInc announced that its CEO, Greg Siokas (@GregSiokas), has issued a letter to the Company’s shareholders: building an innovative AI-driven global healthcare platform — record growth with U.S. expansion underway.
$COSM
globenewswire.com/news-relea…
4
3
5
548
@CosmosHealthInc inaugurates state-of-the-art capsule production line with new 5-year contract manufacturing agreement with Provident Pharmaceuticals for 385,000 units of CERTORUN.
$COSM
globenewswire.com/news-relea…
1
3
7
382
@CosmosHealthInc completes acquisition of strategic intellectual property and expands nanotechnology investment initiatives.
$COSM
globenewswire.com/news-relea…
2
4
8
563
@CosmosHealthInc announced the U.S. launch of Oliv18™️, further expanding its science-driven 18 Series nutraceutical platform into cardiovascular and antioxidant categories.
$COSM
globenewswire.com/news-relea…
6
8
402
@CosmosHealthInc announced that its proprietary brand, Sky Premium Life, is now available for shipment across all 27 European Union Member States through Skroutz, significantly expanding the brand’s international reach.
$COSM
globenewswire.com/news-relea…
4
10
357
@CosmosHealthInc identifies approximately $20 million in non-core assets available for monetization to accelerate growth and unlock shareholder value.
$COSM
globenewswire.com/news-relea…
6
8
335
@CosmosHealthInc provides balance sheet update, reaffirms growth trajectory and notes no known business reason for recent share price decline.
$COSM
globenewswire.com/news-relea…
1
3
7
430
Cosmos Health Inc. (Nasdaq: COSM) retweeted
Jun 1
We are pleased to announce our entry into the animal health industry. The successful testing of C-Scrub Wash 4% under EN 1656 and EN 1657 represents an important milestone as we extend a brand already established in human healthcare into the fast-growing veterinary sector.
$COSM
3
5
6
580
@CosmosHealthInc enters $69 billion global animal health industry with veterinary C-Scrub Wash 4% following successful European standard testing under EN 1656 and EN 1657
$COSM
globenewswire.com/news-relea…
7
11
465
@CosmosHealthInc releases 2026–2029 guidance: targeting $200M revenue, $71M gross profit, and $44M adjusted EBITDA by 2029 - building an innovative, high-margin healthcare platform with strong cash generation.
$COSM
globenewswire.com/news-relea…
1
3
3
633
@CosmosHealthInc announces expiration of 4,874,126 Series B warrants unexercised; approximately 38% of total outstanding warrants.
$COSM
accessnewswire.com/newsroom/…
2
2
7
723
@CosmosHealthInc Q1 2026 results:
✅ Revenue up 31% to $17.9M (highest Q1 in company history)
✅ Total liabilities down $4.5M, or 9.6%
✅ Stockholders’ equity up 7.6%
✅ Record momentum continues into Q2 with US expansion actively underway
$COSM
accessnewswire.com/newsroom/…
1
3
6
627
Our antimicrobial skin cleanser C-Scrub Wash 4% successfully completed testing under EN 12791, the European standard for surgical hand disinfection. We believe this achievement enhances its commercial positioning, supporting expansion into hospital and surgical markets.
$COSM
2
7
745
Cosmos Health Inc. (Nasdaq: COSM) retweeted
May 14
Our subsidiary Cana entered into an advisory agreement with the European Investment Bank for the financing of our €50 million R&D program. Under the EIB Venture Debt Program, potential financing may represent up to 50%, or €25 million, of the total investment.
$COSM
2
4
3
911